Article Information
vol. 9 no. 6
Published By
Online ISSN
History
- Received January 27, 2023
- Accepted August 29, 2023
- Published online November 13, 2023.
Article Versions
- previous version (September 21, 2023 - 06:39).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright ©The authors 2023 This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org
Author Information
- Christian Domingo⇑1,
- Klaus F. Rabe2,3,
- David Price4,5,
- Guy Brusselle6,
- Michael E. Wechsler7,
- Changming Xia8,
- Nami Pandit-Abid9,
- Rebecca Gall8,
- Paul J. Rowe9,
- Yamo Deniz8,
- Juby A. Jacob-Nara9 and
- Amr Radwan8
- 1Pulmonary Service, Corporació Sanitària Parc Taulí, Sabadell, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain
- 2LungenClinic Grosshansdorf (member of the German Center for Lung Research (DZL)), Airway Research Center North (ARCN), Grosshansdorf, Germany
- 3Christian-Albrechts University (member of the DZL), ARCN, Kiel, Germany
- 4Observational and Pragmatic Research Institute, Midview City, Singapore
- 5Centre of Academic Primary Care, Division of Applied Health Sciences, University of Aberdeen, Aberdeen, UK
- 6Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium
- 7Department of Medicine, National Jewish Health, Denver, CO, USA
- 8Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA
- 9Sanofi, Bridgewater, NJ, USA
- Corresponding author: Christian Domingo (cdomingo{at}tauli.cat)
Funding
Regeneron Pharmaceuticals
NCT0213402; NCT02528214Sanofi
NCT0213402; NCT02528214
Article usage
Altmetrics
Vol 9 Issue 6
Table of Contents
Long-term efficacy of dupilumab in severe asthma by baseline oral corticosteroid dose
